MX361186B - Metodo de alta eficiencia para purificar particulas similares a virus del virus del papiloma humano. - Google Patents
Metodo de alta eficiencia para purificar particulas similares a virus del virus del papiloma humano.Info
- Publication number
- MX361186B MX361186B MX2015001413A MX2015001413A MX361186B MX 361186 B MX361186 B MX 361186B MX 2015001413 A MX2015001413 A MX 2015001413A MX 2015001413 A MX2015001413 A MX 2015001413A MX 361186 B MX361186 B MX 361186B
- Authority
- MX
- Mexico
- Prior art keywords
- particles
- high efficiency
- human papillomavirus
- hpv
- efficiency method
- Prior art date
Links
- 241000701806 Human papillomavirus Species 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 239000002245 particle Substances 0.000 title abstract 2
- 238000000746 purification Methods 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000013592 cell lysate Substances 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20051—Methods of production or purification of viral material
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20120083472 | 2012-07-30 | ||
| KR1020130085605A KR101559622B1 (ko) | 2012-07-30 | 2013-07-19 | 인유두종바이러스 바이러스 유사입자의 고효율 정제방법 |
| PCT/KR2013/006823 WO2014021604A1 (ko) | 2012-07-30 | 2013-07-30 | 인유두종바이러스 바이러스 유사입자의 고효율 정제방법 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015001413A MX2015001413A (es) | 2015-11-18 |
| MX361186B true MX361186B (es) | 2018-11-29 |
Family
ID=50266708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015001413A MX361186B (es) | 2012-07-30 | 2013-07-30 | Metodo de alta eficiencia para purificar particulas similares a virus del virus del papiloma humano. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9994618B2 (pt-PT) |
| EP (1) | EP2881401B1 (pt-PT) |
| JP (1) | JP6014763B2 (pt-PT) |
| KR (1) | KR101559622B1 (pt-PT) |
| CN (1) | CN104507956B (pt-PT) |
| AU (1) | AU2013297306B2 (pt-PT) |
| BR (1) | BR112015002126B1 (pt-PT) |
| CA (1) | CA2880420C (pt-PT) |
| CL (1) | CL2015000037A1 (pt-PT) |
| MX (1) | MX361186B (pt-PT) |
| WO (1) | WO2014021604A1 (pt-PT) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112017004181A2 (pt) * | 2014-09-11 | 2017-12-05 | Cadila Healthcare Ltd | ?gene, vetor, célula hospedeira, partículas similares a vírus, vacina para vírus de papiloma humano, composição imunogênica, adjuvante, método para o preparo de uma vacina de papiloma humano, proteína de capsídeo principal e proteína hpv l1? |
| RU2677336C2 (ru) * | 2014-12-26 | 2019-01-16 | Айджин, Инк. | Способ получения вирусоподобных частиц папилломавируса человека |
| CN105176934B (zh) * | 2015-10-16 | 2018-09-18 | 西南大学柑桔研究所 | 柑桔黄化脉明病毒长期离体保存方法 |
| CN109750050B (zh) * | 2017-11-07 | 2023-08-18 | 上海泽润生物科技有限公司 | 重组人乳头瘤病毒45亚型蛋白表达 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE122007000015I2 (de) | 1997-09-05 | 2008-01-24 | Medimmune Inc | Methode zur in Vitro auseinander- und wiederzusammensetzung von Papillomavirus virusähnlichen Teilchen (vlps) |
| US7351533B2 (en) | 1997-09-05 | 2008-04-01 | Medimmune, Inc. | In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents |
| BR9913026A (pt) | 1998-08-14 | 2001-09-25 | Merck & Co Inc | Processo de purificação de partìculas semelhantes a vìrus (vlps) de papilomavìrus recombinante, e, processo de preparação de um produto de vlp de papilomavìrus humano purificado adequado para uso em uma vacina para humano |
| US6245568B1 (en) * | 1999-03-26 | 2001-06-12 | Merck & Co., Inc. | Human papilloma virus vaccine with disassembled and reassembled virus-like particles |
| US6436402B1 (en) | 1999-10-15 | 2002-08-20 | Merck & Co., Inc. | Process for making human papillomavirus virus-like particles with improved properties |
| DE60041889D1 (de) | 1999-12-09 | 2009-05-07 | Medimmune Inc | In-vitro-methode zur zerlegung und zum wiederzusammenfügen von papillomavirusartigen partikeln |
| GB0206360D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
| CN101153280B (zh) | 2006-09-29 | 2015-08-19 | 厦门大学 | 从原核生物中纯化人乳头瘤病毒晚期蛋白l1的方法 |
| CN101139570A (zh) | 2007-04-16 | 2008-03-12 | 马润林 | 一种hpv l1蛋白原核表达的高密度发酵方法 |
| EP2907821B1 (en) | 2007-05-29 | 2016-12-28 | Xiamen University | Method for producing a N-terminaly truncated L1 protein of human papillomavirus (HPV) |
| KR100959145B1 (ko) | 2008-03-21 | 2010-05-25 | 중앙대학교 산학협력단 | 인유두종바이러스 바이러스 유사 입자의 생산 및 정제 방법 |
| NZ590919A (en) | 2008-07-31 | 2012-10-26 | Glaxosmithkline Biolog Sa | Vaccine against hpv |
| AU2009348078B2 (en) | 2009-06-19 | 2013-03-14 | Eyegene Inc. | Vaccine for cervical cancer |
| KR101178056B1 (ko) | 2011-12-19 | 2012-08-28 | 아이진 주식회사 | 자궁경부암 백신 |
-
2013
- 2013-07-19 KR KR1020130085605A patent/KR101559622B1/ko active IP Right Grant
- 2013-07-30 EP EP13824788.7A patent/EP2881401B1/en active Active
- 2013-07-30 JP JP2015525348A patent/JP6014763B2/ja active Active
- 2013-07-30 US US14/418,004 patent/US9994618B2/en active Active
- 2013-07-30 AU AU2013297306A patent/AU2013297306B2/en active Active
- 2013-07-30 BR BR112015002126-3A patent/BR112015002126B1/pt active IP Right Grant
- 2013-07-30 WO PCT/KR2013/006823 patent/WO2014021604A1/ko active Application Filing
- 2013-07-30 CN CN201380040425.9A patent/CN104507956B/zh active Active
- 2013-07-30 MX MX2015001413A patent/MX361186B/es active IP Right Grant
- 2013-07-30 CA CA2880420A patent/CA2880420C/en active Active
-
2015
- 2015-01-08 CL CL2015000037A patent/CL2015000037A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2880420C (en) | 2018-02-27 |
| JP6014763B2 (ja) | 2016-10-25 |
| EP2881401B1 (en) | 2018-04-25 |
| AU2013297306B2 (en) | 2016-09-29 |
| KR101559622B1 (ko) | 2015-10-13 |
| US9994618B2 (en) | 2018-06-12 |
| CA2880420A1 (en) | 2014-02-06 |
| MX2015001413A (es) | 2015-11-18 |
| JP2015524817A (ja) | 2015-08-27 |
| CN104507956A (zh) | 2015-04-08 |
| CN104507956B (zh) | 2018-11-06 |
| KR20140018794A (ko) | 2014-02-13 |
| EP2881401A4 (en) | 2016-04-13 |
| AU2013297306A1 (en) | 2015-02-05 |
| CL2015000037A1 (es) | 2015-07-31 |
| BR112015002126B1 (pt) | 2022-10-04 |
| BR112015002126A2 (pt) | 2017-07-04 |
| US20150266927A1 (en) | 2015-09-24 |
| WO2014021604A1 (ko) | 2014-02-06 |
| EP2881401A1 (en) | 2015-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021006342A (es) | Mutantes de virus de influenza y usos para los mismos. | |
| MX2019004568A (es) | Produccion mejorada de derivados de acidos grasos. | |
| WO2014028453A3 (en) | Natural killer cells and uses thereof | |
| AR091538A1 (es) | Purificacion de particulas tipo virus | |
| TN2012000214A1 (en) | Hepatitis c virus inhibitors | |
| MY152971A (en) | Hepatitis c virus inhibitors | |
| MX2011008045A (es) | Inhibidores del virus de la hepatitis c. | |
| MX2013001579A (es) | Inhibidores del virus de la hepatitis c | |
| WO2011159684A3 (en) | Generation of induced pluripotent stem cells from small volumes of peripheral blood | |
| MX2013001237A (es) | Compuestos inhibidores del virus de la hepatitis c. | |
| MX2007004696A (es) | Metodos de purificacion viral mejorados. | |
| WO2012140127A3 (en) | Method for priming of t cells | |
| WO2011002198A3 (ko) | 산성 가스 흡수 분리 시스템 및 방법 | |
| MX2018010483A (es) | Inmunogenos para vacunacion contra vih. | |
| MX344815B (es) | Metodo para purificar el factor estimulante de colonias de granulocitos humano a partir de e. coli recombinante. | |
| MX2015001413A (es) | Metodo de alta eficiencia para purificar particulas similares a virus del virus del papiloma humano. | |
| MX2014014683A (es) | Peptidos derivados de proteinas virales para usarse como inmunogenos y reactivos de dosificacion. | |
| MX358883B (es) | Aumentar el rendimiento de particulas similares a virus en plantas. | |
| WO2014122629A3 (en) | Improved baculoviral expression system and methods of producing the same | |
| MX2018010346A (es) | Proceso y medio de fermentacion de gas de sintesis. | |
| IN2015DN02772A (pt-PT) | ||
| WO2011154976A3 (en) | Improved influenza vaccine | |
| MY165746A (en) | Method for the production of 2-octyl acrylate by means of transesterification | |
| EP2593548A4 (en) | ANTIGEN E7 COMPOSITIONS OF HUMAN PAPILLOMAVIRUS AND USES THEREOF | |
| WO2012157955A3 (en) | Oil purification method and apparatus with porous membrane |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| PD | Change of proprietorship |
Owner name: POSVAX CO., LTD. |